CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Hem-ID focuses on understanding the genetic and epigenetic factors involved in hematopoiesis and leukemia. The project aims to identify regulatory circuits and develop diagnostic markers and therapeutic strategies to address hematological malignancies.
In hematopoiesis, failure to maintain homeostasis and regenerative functions result in a multitude of hematological malignancies, including myelodysplastic syndromes, lymphomas and leukemias, that represent a medical challenge and a large socioeconomic burden because of the large number of affected patients of all age groups.
Although hierarchical organization of the hematopoietic system has been well defined in the last years, the precise molecular circuits governing the balance between prolife…
UNIVERSITA' DEGLI STUDI DI MILANO-BICOCCA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
CEMM - FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN GMBH
Austria, Wien
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
France, GRENOBLE
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
BIOMEDICALSCIENCES RESEARCH CENTER ALEXANDER FLEMING
Greece, Vari-Athens
Type: Research institute
Activity type: Research Organisations
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
